Drug Database
Back to search

Poland· PL-100080071

Lovastin

A lovastatin product containing lovastatinum, registered in Poland by Gedeon Richter Polska Sp. z o.o.. The same ATC class is registered in 10 of our 19 countries.

ATC C10AA02

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedLovastinATCC10AA02REGISTER NO.PL-100080071PACKS LISTED3CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about lovastatinumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Lovastatin is registered in 10 of 19 countries.

Countries holding a registration under ATC C10AA02 (lovastatin), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 7 of them publish a price we can compare per daily dose
Search lovastatin products by name

Lovastatin · ATC C10AA02

10 / 19 countries

  • Canada
  • Czechiaprice
  • Finlandprice
  • Germany
  • Italyprice
  • Norwayprice
  • Polandprice
  • Spainprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of lovastatin costs, country by country.

Normalised to the WHO defined daily dose (45 mg), the median price runs from $0.20 in Spain to $0.55 in Italy — a ×2.7 gap.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Lovastatin · price per daily dose (45 mg)

USD · FX 28 Sept 2026

  • IT Italy$0.55
  • ES Spain$0.20
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

URPL (Poland)
Active substance
Lovastatinum
Manufacturer
Gedeon Richter Polska Sp. z o.o.
Country
Poland (PL)
ATC code
C10AA02
ATC class
Lovastatin
Defined daily dose
45 mg, O
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 3

  • gtin
    05909990756612
  • gtin
    05909990756629
  • gtin
    05909990422852

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

338 interactions on record for lovastatin.

Graded by severity as the source publishes them — 17 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check lovastatin against other medicinesHow interaction checks work

Lovastatin · interactions on record

338 records

  • 17 severe
  • 176 moderate
  • 4 minor
  • 140 info

Most severe, free to view

  • KetoconazoleH02CA03severe
  • ErythromycinJ01FA01severe
  • ClarithromycinJ01FA09severe
  • KetoconazoleJ02AB02severe

1 more interaction with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Lovastatin in 9 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All lovastatin products

Authorised across Europe · EMA

The same active substance is authorised in 10 EEA countries. Names it is sold under:

  • Cyprus · Lovarem, Lovasynt
  • Czechia · Medostatin
  • Germany · Lovabeta
  • Denmark · Lovacodan
  • Spain · Colesvir, Lovastatina Cinfa
  • Greece · Lovatex, Velkalov
  • Italy · Lovastatina Doc, Lovastatina Eg
  • Malta · Medostatin
  • Portugal · Lipdaune, Lipus
  • Romania · Lovastatină Arena

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f26f8fab-4fe4-44f8-9f41-05fddf2a474f
GET /v1/drugs/f26f8fab-4fe4-44f8-9f41-05fddf2a474f?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki",
  "source": "urpl",
  "strength": "20 mg",
  "packaging": "Rp ¦ Skasowane ¦ 12028\n28 tabl.\n05909990756612 ¦ Rp ¦ Skasowane ¦ 16655\n28 tabl. w pojemniku\n05909990756629 ¦ Rp ¦ 16656\n28 tabl.\n05909990422852 ¦ Rp ¦ Skasowane ¦ 32737\n56 tabl.",
  "substance": "Lovastatinum 20 mg",
  "common_name": "Lovastatinum",
  "pl_product_id": "100080071",
  "pozwolenie_nr": "07566",
  "auth_procedure": "NAR",
  "authorisation_validity": "2024-01-25"
}
API referenceMCP serverPlans

See everything about lovastatin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console